Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticlePROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma

SATOKI KOJIMA, TORU HISAKA, RYUTA MIDORIKAWA, YOSHIKI NAITO, JUN AKIBA, MASAHIKO TANIGAWA, HIROHISA YANO, YOSHITO AKAGI and KOJI OKUDA
Anticancer Research August 2020, 40 (8) 4749-4754; DOI: https://doi.org/10.21873/anticanres.14476
SATOKI KOJIMA
1Department of Surgery, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU HISAKA
1Department of Surgery, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thisaka{at}med.kurume-u.ac.jp
RYUTA MIDORIKAWA
1Department of Surgery, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIKI NAITO
2Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUN AKIBA
2Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIKO TANIGAWA
3Department of Pathology, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROHISA YANO
3Department of Pathology, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITO AKAGI
1Department of Surgery, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI OKUDA
1Department of Surgery, Faculty of Medicine, Kurume University, Kurume, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The purpose of this study was to clarify the relationship between the desmoplastic reaction (DR) and clinicopathological features, and the prognosis using cases of resected intrahepatic cholangiocarcinoma (ICC). Patients and Methods: Out of 54 cases that were preoperatively diagnosed with ICC and underwent resection at our department, 47 patients were included in this study. All sections were prepared from resected specimens and were microscopically observed following H&E staining. Stroma were evaluated at the advancing edge of the cancer and stratified into three DR types: mature (DR1), intermediate (DR2), and immature (DR3). Results: DR was correlated to the serum levels of CA19-9, but not to the other tumor factors. In multivariate analysis, only DR and tumor size were determined as independent prognostic factors. Conclusion: Evaluation of DR for ICC may be useful for prognostic assessments.

  • Desmoplastic reaction
  • intrahepatic cholangiocarcinoma
  • microenvironment

Intrahepatic cholangiocarcinoma (ICC) has poor prognosis, despite the incidence of 3-7% among primary malignant liver tumors. Surgery remains the most effective treatment. There is no clear evidence showing improvement of prognosis from chemotherapy or radiotherapy (1-3).To improve the prognosis of ICC, it is necessary to clarify the factors involved in biological malignancy and the mechanism of involvement of these.

Changes in the local microenvironment transform epithelial cells into high migratory mesenchymal cells, causing tissue remodeling. This process is called epithelial-mesenchymal transition (EMT). When EMT occurs in cancerous epithelial cells, they acquire various malignant traits such as migratory properties, invasive capacity, and resistance to apoptosis. EMT has been related to the metastatic potential of cancer cells and the acquisition of resistance to anticancer drugs (4-7). Desmoplastic reaction (DR) refers to a state in which fibroblasts have proliferated in the stroma. It has been reported that during cancer cell EMT, DR is a result of remodeling of the extracellular matrix in the cancer microenvironment (8).

Recently, DR has been reported to be useful in determining the presence or absence of submucosal invasion in early colorectal cancer. In addition, the relationship between DR and prognosis has been reported for various cancers such as gastric, colorectal, breast, and esophageal (8-10). However, there are few reports on the existence or significance of DR in ICC (11, 12). Clarification of the relationship between stroma and malignancy in ICC is important when considering the indications of surgical treatment, prognosis prediction, and planning postoperative adjuvant therapy for ICC with poor prognosis.

In this study, we examined the relationship between the prognosis and pathological features of DR at the tumor margin.

Patients and Methods

Of the 54 cases that were preoperatively diagnosed with ICC and underwent resection between April 2005 and March 2019 at our hospital, 47 patients with pathologically confirmed ICC after resection, were included in this study.

All sections were prepared from the resected specimens, and microscopic observations were performed following H&E staining. The diagnosis of DR was obtained by two pathologists. When there was a difference in diagnosis, another pathologist joined to reach a final decision. The diagnosis was performed by concealing the clinical features of each case.

This is a retrospective study and was approved by the Ethical committee of the Kurume University School of Medicine (approval no.19266). This was conducted in accordance with the Declaration of Helsinki. An opt-out approach was used to obtain informed consent from the patients, and personal information was protected during date collection.

DR evaluation method. Observations were made at the boundary between the cancerous tissue and normal liver tissue. Classification was conducted according to the criteria reported by Ueno et al. (8). DR1 (mature) was defined as that consisted of thin collagen fibers in multiple layers and cannot be identified as keloid-like fibers or mucus-like stroma. DR2 (intermediate) was defined as that consisted of keloid-like fibers (thick acidophilic collagen fibers) in the stroma of the cancer border. DR3 (immature) as that comprised irregular keloid-like fibers surrounded by a slightly basophilic mucus-like stroma (Figure 1).

Statistical methods. The association between DR and clinicopathological features was analyzed using Fisher's exact test. For clinicopathological features, including DR, the overall survival rate was calculated using the Kaplan-Meier method, and the survival curves were compared using the log-rank test. A p-value of <0.05 was considered statistically significant. Multivariate analysis was conducted on the relationship between survival and clinicopathological factors, including DR, using Cox's proportional hazards model. Statistical analysis was performed using JMP® Pro 11.0.0 (SAS Institute Inc, Cary, NC, USA).

Results

Subject background. The median age was 69 years (range=33-88 years) and the male-to-female ratio was 29:18. The mass-forming type was the most common morphologic subtype, which was observed in 34 cases. The UICC 8th edition (13) was used for staging; 17 cases were T1 and 30 were T2/3. Lymph node metastasis was noted in 11 cases. No arterial invasion was observed, and venous and portal vein invasion was noted in 7 and 27 cases, respectively. The breakdown of DR categorization for DR1, DR2, and DR3 were 15, 12, and 20 cases, respectively. The median serum CA19-9 levels were 41.8 U/ml and the interquartile range was 10.7-528.7 U/ml. The median observation period was 4.3 years (95%CI=1.649-10.151), and the 5-year survival rate was 48% (Table I, Figure 2).

DR and clinical pathological features. The relationship between DR and each clinical pathological feature was analyzed. The clinicopathological feature that had a significant relationship with DR was serum CA19-9. No significant relationship was found with tumor size, histology, lymph node metastasis, vascular invasion, or nerve invasion (Table II).

DR and overall survival rate. Univariate analysis was performed on clinical and pathological factors and survival rate in patients who underwent surgery. A significant relationship was noted with tumor size (p=0.0091), presence or absence of lymph node dissection (p=0.0122), CA19-9 levels (p=0.0007), and DR (p=0.0032). Multivariate analysis, which used these factors as covariates, indicated tumor size and DR as independent prognostic factors (Table III). In the present study, the overall survival (OS) curves of patients with ICC according to DR categorization showed that the median OS of patients with DR1 was 10.2 years (95%CI=4.39-12.93 years), with DR2 was 1.94 (95%CI=0.61-6.03), and with D3 was 2.20 (95%CI=0.91-6.18). The 5-year survival rate of the DR1 group was 87.5%, the DR2 was 32.5%, and DR3 was 35.4%. The difference in OS between the mature type (DR1) and the other types (DR2 and DR3; hereinafter, referred to as “DR2,3”) was significant. The median OS of DR2,3 was 1.95 years (95%CI=1.18-6.18 years), and the 5-year survival rate of that was 34.5% (Figure 3).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Categorization of desmoplastic reaction in intrahepatic cholangiocarcinoma. (A) DR1 (mature) denotes from the presence of thin collagen fibers in multiple layers that cannot be identified as keloid-like fibers or mucus-like stroma. (B) DR2 (intermediate) denotes keloid-like fibers (thick acidophilic collagen fibers) in the stroma of the cancer border. (C) DR3 (immature) denotes irregular keloid-like fibers surrounded by a slightly basophilic mucus-like stroma. (40× magnification, hematoxylin & eosin stain).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Clinicopathological characteristics of patients with ICC undergoing operation.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Correlation between clinicopathological characteristics and DR in ICC.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Overall survival (OS) curves of patients for intrahepatic cholangiocarcinoma after the operation. The median observation period was 4.3 years (95%CI=1.649-10.151), and the 5-year survival rate was 48%.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Overall survival (OS) curves of patients with intrahepatic cholangiocarcinoma according to DR. The median OS of patients with DR1 was 10.2 years (95%CI=4.39-12.93 years), and with DR2,3 was 1.95 years (95%CI=1.18-6.18 years). The 5-year survival rate of patients with DR1 was 87.5%, and those with DR2,3 was 34.5%.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Univariate and multivariate analysis of the prognosis of patients after surgery.

Discussion

Many clinical studies have been reported concerning the poor outcome of patients with ICC after curative-intent surgical resection. In this study, the clinicopathological features of the enrolled patients were similar to those previously reported, and the 5-year survival rate was also similar (1, 3, 14, 15).

Conventionally, the poor prognostic factors for ICC include multiple lesions, tumor size, vascular invasion, lymph node metastasis, cirrhosis, and high levels of CA19-9 (3, 16-18). However, in this study only tumor size and DR were identified as poor prognostic factors in multivariate analysis. Lymph node metastasis tended to be a prognostic factor, but was not statistically significant in our univariate analysis. However, lymph node dissection was a significant prognostic factor in univariate analysis. The prognosis was worse in patients who underwent lymph node dissection than in those who did not. In our surgical strategy, lymph node dissection was performed only in cases of a positive intraoperative lymph node sample biopsy, which may have biased our analysis results of no relationship between lymph node metastasis and the prognosis.

Regarding DR categorization, there were cases where it was difficult to distinguish between DR2 and DR3. However, DR1, which indicates mature stroma, and DR2,3 tend to be clearly distinguishable histologically, with significant relationship in the overall survival rate between the DR1 and DR2,3 groups. The mature type (DR1) had significantly better prognosis than the non-mature types (intermediate type: DR2, immature type: DR3). There were 15 cases diagnosed as DR1. Some cases had a more than 10 years postoperative follow up period, but only 4 deaths were noted and long-term survival was obtained. Due to this, the hazard ratio may have become extremely high.

Regarding DR in colorectal cancer, there are reports on the correlation between lymphatic invasion, lymph node metastasis, and DR (8). However, in contrast to expectations, no correlation was found between lymph node metastasis and DR in this study. Further, several factors which have been reported to be the prognostic factors were not correlated to DR except CA19-9. Typically, previous clinicopathological prognostic factors were based on the evaluation of the cancer cells themselves. Recently, the evaluation of the cancer microenvironment has been gaining attention as it is consider to be related to malignant potential, prognosis and recurrence (9, 19). It is known that the EMT mechanism is greatly affected by the microenvironment around cancer cells. This study suggested that the more immature, the poor prognosis, but also the DR may be related to the malignant aggressiveness of ICC, such as the levels of tumor markers (serum CA19-9). In addition, Ueno et al. have reported (9) that although carcinomas differ, there is a relationship between the budding and DR in the advanced part of the cancer. The tumor and stromal microenvironment in ICC are likely to affect prognosis. Moving forward, the clarification of relationship between the EMT phenotypes of tumors, such as budding and spindle-shaped cells, and stroma may be useful in prognosis prediction and determining the pros and cons of postoperative adjuvant chemotherapy in ICC with poor prognosis. Furthermore, the clarification of the involvement of genes related to EMT (Snail family, ZEB family, twist, Slug, CDH2, CAFs, etc.) may contribute to the establishment of new therapeutic methods.

This study has limitations. It was a retrospective study, with a limited number of cases, performed at a single institution. Additionally, the reproducibility of DR evaluation and its association with the tumors should be validated by further research. The advantage, which we emphasize, is that the evaluation of tumor type and DR can be performed with the same H&E staining, which is an inexpensive and simple method.

In conclusion, we report that an immature desmoplastic reaction in ICC affects survival rate. In the future, if the relationship between tumor and DR will be validated and clarified, it might contribute to the identification of genes related to the establishment of the cancer microenvironment in ICC.

Acknowledgements

The Authors are grateful to all patients and their families for providing the opportunity to conduct the present research project. The Authors also thanks Ms. M. Toyofuku for continuing support.

Footnotes

  • Authors' Contributions

    Satoki Kojima designed the study and wrote the initial draft of the manuscript. Satoki Kojima and Toru Hisaka contributed to analysis and interpretation of data and assisted in the preparation of the manuscript. All the other Authors contributed to data collection and interpretation and critically reviewed the manuscript. All Authors approved the final version of the manuscript, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • This article is freely accessible online.

  • Conflicts of Interest

    No conflicts of interest exist regarding this study.

  • Received May 23, 2020.
  • Revision received June 14, 2020.
  • Accepted June 15, 2020.
  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Doussot A,
    2. Gonen M,
    3. Wiggers JK,
    4. Groot-Koerkamp B,
    5. DeMatteo RP,
    6. Fuks D,
    7. Allen PJ,
    8. Farges O,
    9. Kingham TP,
    10. Regimbeau JM,
    11. D'Angelica MI,
    12. Azoulay D,
    13. Jarnagin WR
    : Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: Preoperative and postoperative prognostic models. J Am Coll Surg 223(3): 493-505 e492, 2016. PMID: 27296525. DOI: 10.1016/j.jamcollsurg.2016.05.019
    OpenUrl
    1. Hyder O,
    2. Hatzaras I,
    3. Sotiropoulos GC,
    4. Paul A,
    5. Alexandrescu S,
    6. Marques H,
    7. Pulitano C,
    8. Barroso E,
    9. Clary BM,
    10. Aldrighetti L,
    11. Ferrone CR,
    12. Zhu AX,
    13. Bauer TW,
    14. Walters DM,
    15. Groeschl R,
    16. Gamblin TC,
    17. Marsh JW,
    18. Nguyen KT,
    19. Turley R,
    20. Popescu I,
    21. Hubert C,
    22. Meyer S,
    23. Choti MA,
    24. Gigot JF,
    25. Mentha G,
    26. Pawlik TM
    : Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery 153(6): 811-818, 2013. PMID: 23499016. DOI: 10.1016/j.surg.2012.12.005
    OpenUrlPubMed
  2. ↵
    1. Yamashita YI,
    2. Shirabe K,
    3. Beppu T,
    4. Eguchi S,
    5. Nanashima A,
    6. Ohta M,
    7. Ueno S,
    8. Kondo K,
    9. Kitahara K,
    10. Shiraishi M,
    11. Takami Y,
    12. Noritomi T,
    13. Okamoto K,
    14. Ogura Y,
    15. Baba H,
    16. Fujioka H
    : Surgical management of recurrent intrahepatic cholangiocarcinoma: Predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the kyushu study group of liver surgery. Ann Gastroenterol Surg 1(2): 136-142, 2017. PMID: 29863136. DOI: 10.1002/ags3.12018
    OpenUrl
  3. ↵
    1. Mani SA,
    2. Guo W,
    3. Liao MJ,
    4. Eaton EN,
    5. Ayyanan A,
    6. Zhou AY,
    7. Brooks M,
    8. Reinhard F,
    9. Zhang CC,
    10. Shipitsin M,
    11. Campbell LL,
    12. Polyak K,
    13. Brisken C,
    14. Yang J,
    15. Weinberg RA
    : The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4): 704-715, 2008. PMID: 18485877. DOI: 10.1016/j.cell.2008.03.027
    OpenUrlCrossRefPubMed
    1. Fischer KR,
    2. Durrans A,
    3. Lee S,
    4. Sheng J,
    5. Li F,
    6. Wong ST,
    7. Choi H,
    8. El Rayes T,
    9. Ryu S,
    10. Troeger J,
    11. Schwabe RF,
    12. Vahdat LT,
    13. Altorki NK,
    14. Mittal V,
    15. Gao D
    : Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527(7579): 472-476, 2015. PMID: 26560033. DOI: 10.1038/nature15748
    OpenUrlCrossRefPubMed
    1. Zheng X,
    2. Carstens JL,
    3. Kim J,
    4. Scheible M,
    5. Kaye J,
    6. Sugimoto H,
    7. Wu CC,
    8. LeBleu VS,
    9. Kalluri R
    : Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527(7579): 525-530, 2015. PMID: 26560028. DOI: 10.1038/nature16064
    OpenUrlCrossRefPubMed
  4. ↵
    1. Ceausu AR,
    2. Ciolofan A,
    3. Cimpean AM,
    4. Magheti A,
    5. Mederle O,
    6. Raica M
    : The mesenchymal-epithelial and epithelial-mesenchymal cellular plasticity of liver metastases with digestive origin. Anticancer Res 38(2): 811-816, 2018. PMID: 29374706. DOI: 10.21873/anticanres.12288
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Ueno H,
    2. Shinto E,
    3. Kajiwara Y,
    4. Fukazawa S,
    5. Shimazaki H,
    6. Yamamoto J,
    7. Hase K
    : Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer 111(11): 2082-2090, 2014. PMID: 25247323. DOI: 10.1038/bjc.2014.509
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ueno H,
    2. Shinto E,
    3. Shimazaki H,
    4. Kajiwara Y,
    5. Sueyama T,
    6. Yamamoto J,
    7. Hase K
    : Histologic categorization of desmoplastic reaction: Its relevance to the colorectal cancer microenvironment and prognosis. Ann Surg Oncol 22(5): 1504-1512, 2015. PMID: 25395146. DOI: 10.1245/s10434-014-4149-9
    OpenUrl
  7. ↵
    1. Aslan M,
    2. Shahbazi R,
    3. Ulubayram K,
    4. Ozpolat B
    : Targeted therapies for pancreatic cancer and hurdles ahead. Anticancer Res 38(12): 6591-6606, 2018. PMID: 30504367. DOI: 10.21873/anticanres.13026
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Fabris L,
    2. Perugorria MJ,
    3. Mertens J,
    4. Bjorkstrom NK,
    5. Cramer T,
    6. Lleo A,
    7. Solinas A,
    8. Sanger H,
    9. Lukacs-Kornek V,
    10. Moncsek A,
    11. Siebenhuner A,
    12. Strazzabosco M
    : The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver Int 39(Suppl 1): 63-78, 2019. PMID: 30907492. DOI: 10.1111/liv.14098
    OpenUrl
  9. ↵
    1. Aghamaliyev U,
    2. Gaitantzi H,
    3. Thomas M,
    4. Simon-Keller K,
    5. Gaiser T,
    6. Marx A,
    7. Yagublu V,
    8. Araos J,
    9. Cai C,
    10. Valous NA,
    11. Halama N,
    12. Kiesslich T,
    13. Ebert M,
    14. Grutzmann R,
    15. Ruckert F,
    16. Breitkopf-Heinlein K
    : Downregulation of sparc is associated with epithelial-mesenchymal transition and low differentiation state of biliary tract cancer cells. Eur Surg Res 60(1-2): 1-12, 2019. PMID: 30650425. DOI: 10.1159/000494734
    OpenUrl
  10. ↵
    1. Brierley JD,
    2. Gospodarowicz MK,
    3. Wittekind C
    : TNM classification of malignant tumours. Wiley, 2016.
  11. ↵
    1. Nakano M,
    2. Ariizumi SI,
    3. Yamamoto M
    : Intrahepatic cholangiocarcinoma. Semin Diagn Pathol 34(2): 160-166, 2017. PMID: 28094162. DOI: 10.1053/j.semdp.2016.12.012
    OpenUrl
  12. ↵
    1. Kudo M,
    2. Izumi N,
    3. Kubo S,
    4. Kokudo N,
    5. Sakamoto M,
    6. Shiina S,
    7. Tateishi R,
    8. Nakashima O,
    9. Murakami T,
    10. Matsuyama Y,
    11. Takahashi A,
    12. Miyata H,
    13. Takayama T
    : Report of the 20th nationwide follow-up survey of primary liver cancer in japan. Hepatol Res 50(1): 15-46, 2020. PMID: 31655492. DOI: 10.1111/hepr.13438
    OpenUrl
  13. ↵
    1. Wang Y,
    2. Li J,
    3. Xia Y,
    4. Gong R,
    5. Wang K,
    6. Yan Z,
    7. Wan X,
    8. Liu G,
    9. Wu D,
    10. Shi L,
    11. Lau W,
    12. Wu M,
    13. Shen F
    : Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31(9): 1188-1195, 2013. PMID: 23358969. DOI: 10.1200/JCO.2012.41.5984
    OpenUrlAbstract/FREE Full Text
    1. Spolverato G,
    2. Kim Y,
    3. Alexandrescu S,
    4. Marques HP,
    5. Lamelas J,
    6. Aldrighetti L,
    7. Clark Gamblin T,
    8. Maithel SK,
    9. Pulitano C,
    10. Bauer TW,
    11. Shen F,
    12. Poultsides GA,
    13. Tran TB,
    14. Wallis Marsh J,
    15. Pawlik TM
    : Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol 23(1): 235-243, 2016. PMID: 26059651. DOI: 10.1245/s10434-015-4642-9
    OpenUrl
  14. ↵
    1. Hu LS,
    2. Zhang XF,
    3. Weiss M,
    4. Popescu I,
    5. Marques HP,
    6. Aldrighetti L,
    7. Maithel SK,
    8. Pulitano C,
    9. Bauer TW,
    10. Shen F,
    11. Poultsides GA,
    12. Soubrane O,
    13. Martel G,
    14. Koerkamp BG,
    15. Itaru E,
    16. Pawlik TM
    : Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol 26(8): 2549-2557, 2019. PMID: 31020501. DOI: 10.1245/s10434-019-07353-4
    OpenUrl
  15. ↵
    1. Sis B,
    2. Sarioglu S,
    3. Sokmen S,
    4. Sakar M,
    5. Kupelioglu A,
    6. Fuzun M
    : Desmoplasia measured by computer assisted image analysis: An independent prognostic marker in colorectal carcinoma. J Clin Pathol 58(1): 32-38, 2005. PMID: 15623479. DOI: 10.1136/jcp.2004.018705
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma
SATOKI KOJIMA, TORU HISAKA, RYUTA MIDORIKAWA, YOSHIKI NAITO, JUN AKIBA, MASAHIKO TANIGAWA, HIROHISA YANO, YOSHITO AKAGI, KOJI OKUDA
Anticancer Research Aug 2020, 40 (8) 4749-4754; DOI: 10.21873/anticanres.14476

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma
SATOKI KOJIMA, TORU HISAKA, RYUTA MIDORIKAWA, YOSHIKI NAITO, JUN AKIBA, MASAHIKO TANIGAWA, HIROHISA YANO, YOSHITO AKAGI, KOJI OKUDA
Anticancer Research Aug 2020, 40 (8) 4749-4754; DOI: 10.21873/anticanres.14476
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
  • Google Scholar

More in this TOC Section

PROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

  • Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion
  • The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
  • Clinical Outcomes of Surgical Resection for Brain Metastases from Non-small Cell Lung Cancer
Show more PROCEEDINGS OF THE 23RD ANNUAL MEETING OF THE SOCIETY OF BIOTHERAPEUTIC APPROACHES

Clinical Studies

  • Real-world Comparative Study of Androgen Receptor Signaling Inhibitors in Japanese Patients With Non-metastatic Castration-resistant Prostate Cancer
  • Adverse Events and Safety Outcomes Associated With Chemotherapy for Inflammatory Bowel Disease–associated Gastrointestinal Cancers
  • Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
Show more Clinical Studies

Keywords

  • Desmoplastic reaction
  • Intrahepatic cholangiocarcinoma
  • microenvironment
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire